JPS646262A - Morpholine derivative, manufacture and medicinal composition - Google Patents

Morpholine derivative, manufacture and medicinal composition

Info

Publication number
JPS646262A
JPS646262A JP63053888A JP5388888A JPS646262A JP S646262 A JPS646262 A JP S646262A JP 63053888 A JP63053888 A JP 63053888A JP 5388888 A JP5388888 A JP 5388888A JP S646262 A JPS646262 A JP S646262A
Authority
JP
Japan
Prior art keywords
manufacture
medicinal composition
morpholine derivative
morpholine
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP63053888A
Other languages
English (en)
Inventor
Robaato Sandaazu Aak Jiyonasan
Harorudo Rojiyaazu Nooman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878705587A external-priority patent/GB8705587D0/en
Priority claimed from GB888803261A external-priority patent/GB8803261D0/en
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of JPS646262A publication Critical patent/JPS646262A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Fodder In General (AREA)
JP63053888A 1987-03-10 1988-03-09 Morpholine derivative, manufacture and medicinal composition Pending JPS646262A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878705587A GB8705587D0 (en) 1987-03-10 1987-03-10 Compounds
GB888803261A GB8803261D0 (en) 1988-02-12 1988-02-12 Compounds & treatment

Publications (1)

Publication Number Publication Date
JPS646262A true JPS646262A (en) 1989-01-10

Family

ID=26291994

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63053888A Pending JPS646262A (en) 1987-03-10 1988-03-09 Morpholine derivative, manufacture and medicinal composition

Country Status (9)

Country Link
US (2) US4914202A (ja)
EP (1) EP0290122B1 (ja)
JP (1) JPS646262A (ja)
AU (2) AU598644B2 (ja)
DE (1) DE3876846T2 (ja)
DK (1) DK123788A (ja)
HU (1) HU199440B (ja)
NZ (1) NZ223812A (ja)
PT (1) PT86919B (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6265402B1 (en) 1996-08-27 2001-07-24 Nikken Chemicals Co., Ltd. Use of 2-phenylmorpholin-5-one derivatives

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5281623A (en) * 1990-08-27 1994-01-25 Eli Lilly And Company Method for treating inflammation
EP1112073A4 (en) * 1998-08-12 2002-10-25 Smithkline Beecham Corp CALCILYTIC COMPOUNDS
WO2014108449A1 (en) 2013-01-08 2014-07-17 Atrogi Ab A screening method, a kit, a method of treatment and a compound for use in a method of treatment
WO2018085886A1 (en) * 2016-11-09 2018-05-17 Charles Sturt University Livestock supplement and use thereof
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB202205895D0 (en) 2022-04-22 2022-06-08 Atrogi Ab New medical uses
WO2024153813A1 (en) 2023-01-20 2024-07-25 Atrogi Ab Beta 2-adrenergic receptor agonists for treatment or prevention of muscle wasting
GB202302225D0 (en) 2023-02-16 2023-04-05 Atrogi Ab New medical uses
GB202303229D0 (en) 2023-03-06 2023-04-19 Atrogi Ab New medical uses

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2832777A (en) * 1956-11-26 1958-04-29 Searle & Co 2-aminophenyl-3-methylmorpholines
US3192208A (en) * 1962-07-31 1965-06-29 Lilly Co Eli Novel substituted morpholines and piperazines and processes for their synthesis
US3256278A (en) * 1963-04-01 1966-06-14 Rexall Drug Chemical N-hydroxy ethyl-ortho acetyl and carbalkoxy amino phenyl-glyoxamides and process formaking 2-orthoamino phenyl-morpholines
US4404222A (en) * 1980-08-25 1983-09-13 American Cyanamid Company Phenylethanolamine derivatives and acid addition salts thereof for enhancing the growth rate of meat-producing animals and improving the efficiency of feed utilization thereby
EP0049728B1 (en) * 1980-08-25 1986-11-12 American Cyanamid Company Method for enhancing the growth rate of meat-producing animals and for improving the lean meat to fat ratio thereof
EP0140359B1 (en) * 1983-11-02 1989-01-25 Beecham Group Plc Morpholine derivatives
GB8412862D0 (en) * 1984-05-19 1984-06-27 Beecham Group Plc Compounds
GB8418657D0 (en) * 1984-07-21 1984-08-22 Beecham Group Plc Compounds
PT82120B (en) * 1985-03-01 1988-06-16 Beecham Group Plc Process for preparing veterinary formulations containing ethanolamine derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6265402B1 (en) 1996-08-27 2001-07-24 Nikken Chemicals Co., Ltd. Use of 2-phenylmorpholin-5-one derivatives

Also Published As

Publication number Publication date
PT86919B (pt) 1992-05-29
HU199440B (en) 1990-02-28
EP0290122A1 (en) 1988-11-09
EP0290122B1 (en) 1992-12-23
NZ223812A (en) 1991-11-26
AU1279788A (en) 1988-09-08
PT86919A (pt) 1988-04-01
HUT49594A (en) 1989-10-30
US5082840A (en) 1992-01-21
DK123788D0 (da) 1988-03-08
US4914202A (en) 1990-04-03
AU598644B2 (en) 1990-06-28
DE3876846T2 (de) 1993-04-29
DE3876846D1 (de) 1993-02-04
DK123788A (da) 1988-09-11
AU6301990A (en) 1991-01-10

Similar Documents

Publication Publication Date Title
JPS6413076A (en) Novel compound, manufacture and medicinal composition
JPS6426578A (en) 2,2-dimethylchroman-3-ol derivative, manufacture and drug composition
IL77004A0 (en) 5-amino-4-hydroxyvaleryl derivatives,their manufacture and pharmaceutical compositions containing them
JPS5753449A (en) 2-hydroxy-5-phenylazobenzoic acid derivative, manufacture and medicinal composition
IL74882A0 (en) Naphthyridine-,quinoline-and benzoxazine-carboxylic acids and derivatives thereof,their manufacture and pharmaceutical compositions containing them
IL85972A0 (en) Cephalosporin derivatives,their manufacture and pharmaceutical compositions containing them
EP0288973A3 (en) Benzothiazolinone derivatives, their production and pharmaceutical composition
JPS5711966A (en) Pyridoxine derivative,manufacture and medicinal use
JPS6413088A (en) Novel compound, manufacture and medicinal composition
IL84765A0 (en) Pyridazodiazepine derivatives,their manufacture and pharmaceutical compositions containing them
JPS6413070A (en) Novel compound, manufacture and medicinal composition
JPS6470458A (en) Alkylaminoalkoxyphenyl derivative, manufacture and composition
JPS646262A (en) Morpholine derivative, manufacture and medicinal composition
JPS57192366A (en) Acylquinolinone derivative, manufacture, drug blend containing same and use
JPS6479146A (en) Drug composition
IL87374A0 (en) Cephalosporin derivatives,their manufacture and pharmaceutical compositions containing them
NZ226516A (en) 2,2 dimethylchromene derivatives and pharmaceutical compositions
IL85722A0 (en) Propiolophenone derivatives,their manufacture and pharmaceutical compositions containing them
JPS6452763A (en) Novel heterocyclic derivative, manufacture and medicinal composition
IL85970A0 (en) Cephalosporin derivatives,their manufacture and pharmaceutical compositions containing them
IL79120A0 (en) Glycerol derivatives,their manufacture and pharmaceutical compositions containing them
JPS6422863A (en) Aminocyclopentyl ether, manufacture and medicinal composition
NZ227235A (en) Substituted 1,5-benzothiazepin-4-one derivatives and pharmaceutical compositions
IL85624A0 (en) Imidazodiazepine derivatives,their manufacture and pharmaceutical compositions containing them
IL90958A0 (en) Cycloalkylthiazole derivatives,their manufacture and pharmaceutical compositions containing them